Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; removed Revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-23T04:59:05.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the prior revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-08T23:52:20.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history.
    Difference
    0.1%
    Check dated 2026-02-15T12:30:59.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study record history shows a new revision (v3.4.1) added and the previous revision (v3.4.0) removed.
    Difference
    0.1%
    Check dated 2026-02-08T04:57:00.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, a color-coded legend for additions and deletions (green/red), and new revision notes (v3.4.0), with minor wording changes such as 'No FEAR Act Data'.
    Difference
    1%
    Check dated 2026-01-24T23:03:53.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A new record version (v3.3.4) has been added to the Record History, reflecting updates to recruitment status, study status, and study design.
    Difference
    0.1%
    Check dated 2026-01-17T23:25:34.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.